Cargando…

The National Osteoporosis Foundation’s position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations

Lifestyle choices influence 20–40 % of adult peak bone mass. Therefore, optimization of lifestyle factors known to influence peak bone mass and strength is an important strategy aimed at reducing risk of osteoporosis or low bone mass later in life. The National Osteoporosis Foundation has issued thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weaver, C. M., Gordon, C. M., Janz, K. F., Kalkwarf, H. J., Lappe, J. M., Lewis, R., O’Karma, M., Wallace, T. C., Zemel, B. S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer London 2016
Materias:	Position Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791473/ https://www.ncbi.nlm.nih.gov/pubmed/26856587 http://dx.doi.org/10.1007/s00198-015-3440-3

Ejemplares similares

Erratum to: The National Osteoporosis Foundation’s position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations
por: Weaver, C. M., et al.
Publicado: (2016)

Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report
por: Rizzoli, R., et al.
Publicado: (2010)

The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group
por: Siris, E. S., et al.
Publicado: (2014)

Roadmap for the Development of Academic and Medical Applications of Blockchain Technology: Joint Statement from OPUS 12 Global and Litecoin Cash Foundation
por: Stawicki, Stanislaw Peter, et al.
Publicado: (2019)

Is it time to consider population screening for fracture risk in postmenopausal women? A position paper from the International Osteoporosis Foundation Epidemiology/Quality of Life Working Group
por: Chotiyarnwong, P., et al.
Publicado: (2022)

CSACI position statement: transition recommendations on existing epinephrine autoinjectors
por: Li, Lucy Dong Xuan, et al.
Publicado: (2021)

Position statement on radiopharmaceutical production for clinical trials
por: Bormans, G., et al.
Publicado: (2017)

Real-world evidence: new opportunities for osteoporosis research. Recommendations from a Working Group from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
por: Moon, Rebecca J., et al.
Publicado: (2023)

Update on the clinical use of trabecular bone score (TBS) in the management of osteoporosis: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), and the International Osteoporosis Foundation (IOF) under the auspices of WHO Collaborating Center for Epidemiology of Musculoskeletal Health and Aging
por: Shevroja, Enisa, et al.
Publicado: (2023)

Joint position statement on management of patient with osteoporosis during COVID-19 contingency from the AMMOM, CONAMEGER, FELAEN, FEMECOG, FEMECOT, and ICAAFYD
por: Torres-Naranjo, Francisco, et al.
Publicado: (2021)

Position Statements
Publicado: (2009)

Position Statements
Publicado: (2011)

Position Statements
Publicado: (2010)

Position Statements
Publicado: (2012)

Scientific Statements
Publicado: (2013)

Position Statements
Publicado: (2013)

A patient-level key performance indicator set to measure the effectiveness of fracture liaison services and guide quality improvement: a position paper of the IOF Capture the Fracture Working Group, National Osteoporosis Foundation and Fragility Fracture Network
por: Javaid, M. K., et al.
Publicado: (2020)

ACMT Position Statement: Medication Administration and Safety During the Response to COVID-19 Pandemic
por: Farmer, Brenna M., et al.
Publicado: (2020)

Academic College of Emergency Experts in India's INDO-US Joint Working Group and OPUS12 Foundation Consensus Statement on Creating A Coordinated, Multi-Disciplinary, Patient-Centered, Global Point-of-Care Biomarker Discovery Network
por: Stawicki, Stanislaw P., et al.
Publicado: (2014)

Publication outcomes of the abstracts presented at the 2011 European Congress on Osteoporosis, Osteoarthritis and Musculo-Skeletal Diseases (ECCEO-IOF11): A position paper of the European Society for Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculo-Skeletal Diseases (ESCEO) and the International Osteoporosis and Other Skeletal Diseases Foundation (IOF)
por: Rabenda, Véronique, et al.
Publicado: (2015)

Thai Osteoporosis Foundation (TOPF) position statements on management of osteoporosis
por: Songpatanasilp, T., et al.
Publicado: (2016)

UK clinical guideline for the prevention and treatment of osteoporosis
por: Compston, J., et al.
Publicado: (2017)

Type 1 Diabetes in Children and Adolescents: A Position Statement by the American Diabetes Association
por: Chiang, Jane L., et al.
Publicado: (2018)

Australasian Sleep Association position statement on consensus and evidence based treatment for primary snoring
por: Sarkis, Leba M., et al.
Publicado: (2023)

Clinician’s Guide to Prevention and Treatment of Osteoporosis
por: Cosman, F., et al.
Publicado: (2014)

ACMT Position Statement: Off-Label Prescribing during COVID-19 Pandemic
por: Stolbach, Andrew I., et al.
Publicado: (2020)

Diabetic Neuropathy: A Position Statement by the American Diabetes Association
por: Pop-Busui, Rodica, et al.
Publicado: (2017)

Diabetic Retinopathy: A Position Statement by the American Diabetes Association
por: Solomon, Sharon D., et al.
Publicado: (2017)

Surgical management of obstructive sleep apnoea: A position statement of the Australasian Sleep Association(*)
por: MacKay, Stuart G., et al.
Publicado: (2020)

Thoracic Society of Australia and New Zealand Position Statement: Respiratory nursing
por: Smith, Sheree M. S., et al.
Publicado: (2022)

Dietitians Australia position statement on telehealth
por: Kelly, Jaimon T., et al.
Publicado: (2020)

Genetic and metabolic investigations for neurodevelopmental disorders: position statement of the Canadian College of Medical Geneticists (CCMG)
por: Carter, Melissa T, et al.
Publicado: (2023)

Position Statement on Exercise Dosage in Rheumatic and Musculoskeletal Diseases: The Role of the IMPACT-RMD Toolkit
por: Metsios, George S., et al.
Publicado: (2021)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women
por: Kanis, J.A., et al.
Publicado: (2018)

ACMT Position Statement: Caring for Patients with Opioid Use Disorder during Coronavirus Disease Pandemic
por: Stolbach, Andrew, et al.
Publicado: (2020)

Position statement for the diagnosis and management of anogenital warts
por: O'Mahony, C., et al.
Publicado: (2019)

Position statement on the role of healthcare professionals, patient organizations and industry in European Reference Networks
por: Hollak, Carla E. M., et al.
Publicado: (2016)

Electronic cigarettes: A position statement from the Thoracic Society of Australia and New Zealand*
por: McDonald, Christine F., et al.
Publicado: (2020)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women
por: Kanis, J. A., et al.
Publicado: (2012)

Graves’ orbitopathy as a rare disease in Europe: a European Group on Graves’ Orbitopathy (EUGOGO) position statement
por: Perros, P., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_n4p3ond1hd8cnt7m8bglgcb4qk